专肽生物_定制多肽合成服务_多肽合成定制服务_多肽合成厂家_多肽合成公司

Amylin (8-37), rat 是天然胰淀素的一种截短肽段，其选择性抑制肌肉组织中胰岛素相关的葡萄糖摄取和糖原沉积。Amylin (8-37), rat 是一种稍弱的胰淀素受体 (amylin receptor, AMY) 拮抗剂。

Amylin (8-37), rat is a truncated analog of native Amylin that selectively inhibits insulin-related glucose uptake and glycogen deposition in muscle tissue. Amylin (8-37), rat is a weak amylin receptor (AMY) antagonist.

一种胰淀素受体拮抗剂，可减弱链脲佐菌素治疗大鼠的ANP释放。

An amylin receptor antagonist that attenuates the ANP release in streptozotocin-treated rats.

Amylin (8-37) (mouse, rat)是天然Amylin一种截短肽段的类似物，其选择性抑制肌肉组织中胰岛素相关的葡萄糖摄取和糖原沉积。Amylin (8-37) (mouse, rat)是一种稍弱的胰淀素受体 (amylin receptor, AMY) 拮抗剂。
 

胰淀素(Amylin)的定义

胰淀素或胰岛淀粉样多肽（IAPP）是一种由胰腺β细胞分泌的37个氨基酸组成的肽，是2型糖尿病患者淀粉样蛋白沉积物的主要成分。胰淀素可被称为胰岛素的“孪生兄弟”，因为它在血浆葡萄糖升高时与胰岛素一起组成性表达。

Amylin or Islet amyloid polypeptide (IAPP), a 37-amino acid peptide is secreted by beta-islet cells of the pancreas and a major component of the amyloid deposits in persons with type 2 diabetes mellitus. Amylin may be referred to as insulin’s “fraternal twin” as it is constitutively expressed with insulin in response to elevations of plasma glucose.

胰淀素(Amylin)的发现

胰岛淀粉样蛋白沉积是糖尿病的主要病理特征，这一知识已为人所知一个世纪。但是，淀粉样蛋白沉积的主要成分胰淀素的发现，是由两个独立的研究小组在1987年完成的【1】【2】。

The knowledge of occurrence of amyloid deposits in islets of Langerhans, major pathologic feature of diabetics has been known for a century. But, the discovery of amylin as a major component of amyloid deposits was by two independent groups in 1987【1】【2】.

胰淀素(Amylin)的结构特征

人胰淀素具有氨基酸序列KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY，其中半胱氨酸残基2和7之间存在二硫键。这些特征、酰胺化的C末端和二硫键对于胰淀素的完全生物活性是必需的【3】。胰淀素的氨基酸序列与降钙素基因相关神经肽CGRP-2和CGRP-1的氨基酸序列分别有46%和43%的相似性。胰淀素的（20-29）片段对胰岛淀粉样蛋白的发病机制至关重要【4】。

The human amylin has an amino acid sequence KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY, with a disulfide bridge between cysteine residues 2 and 7. The features, amidated C-terminus and the disulfide bridge are necessary for the full biological activity of amylin【3】. Amylin amino acid sequence is 46% and 43% identical to those of the calcitonin gene-related neuropeptides CGRP-2 and CGRP-1. The (20-29) fragment of amylin is critical to the pathogenesis of islet amyloid【4】.

胰淀素(Amylin)的作用机制

胰淀素由胰岛β细胞合成，在高尔基体中包装，并在分泌颗粒内分泌。它在肾皮质中的肾小球旁体区域有结合位点，并能激活肾素-血管紧张素-醛固酮系统。此外，它还通过抑制心钠素（ANP）的分泌来作用于循环系统【5】。

Amylin is synthesized, packaged within the golgi apparatus and secreted within the secretory granule by the islet beta cell. They have binding sites within the renal cortex in the area of the juxtaglomerular apparatus and it activates the rennin angiotensin aldosterone system. It also acts upon the circulatory system by inhibiting the secretion of the atrial natriuretic peptide (ANP)【5】.

胰淀素(Amylin)的功能

胰淀素抑制胃排空，在控制和延缓餐后葡萄糖释放速率方面起着重要作用。它抑制餐后肝脏释放和葡萄糖生成。研究还表明，胰淀素能抑制胰高血糖素分泌和生长抑素。胰淀素通过扩张血管的非横纹肌来引起血管舒张。此外，胰淀素还能增加口渴感，这表明它在中枢神经系统内也有作用【6】。

Amylin inhibits gastric emptying and is important in controlling and delaying the rate of meal derived glucose. It inhibits hepatic release and production of glucose in the postprandial period. They also have been shown to inhibit glucagon secretion and somatostatin. Amylin causes vasodilatation by dilating the non-striated muscles of the blood vessels. It is also known to increase thirst level which indicates it has an action within the central nervous system【6】.

胰淀素(Amylin)的相关文献

1.     Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB (1987). Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci., 84(23):8628-32.
2.     Westermark P, Wernstedt C, O'Brien TD, Hayden DW, Johnson KH (1987). Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol, 127(3):414-417.
3.     Roberts AN, Leighton B, Todd JA, Cockburn D, Schofield PN, Sutton R, Holt S, Boyd Y, Day AJ, Foot EA, et al,(1989). Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus. Proc Natl Acad Sci, 86(24):9662-9666.
4.     Guidobono F, Pagani F, Ticozzi C, Sibilia V, Pecile A, Netti C (1997). Protection by amylin of gastric erosions induced by indomethacin or ethanol in rats. Br J Pharmacol, 120(4):581-586.
5.     Piao FL, Cao C, Han JH, Kim SZ, Cho KW, Kim SH (2004). Amylin-induced suppression of ANP secretion through receptors for CGRP1 and salmon calcitonin. Regul Pept, 117: 59-166.
6.     Hayden MR, Tyagi SC (2002). Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus. Journal of the Pancrease, 3(4): 86-108.

【拮抗剂多肽在癌症治疗中的作用机制】

       1 、抑制肿瘤细胞增殖：某些多肽能够直接作用于肿瘤细胞，干扰其增殖信号传导路径，从而抑制肿瘤细胞的增长。

       2 、诱导肿瘤细胞凋亡：多肽可以通过模拟肿瘤抑制蛋白或激活凋亡信号通路，促进肿瘤细胞走向程序性死亡。

       3 、免疫调节：多肽类化合物能够激活机体的免疫系统，增强免疫细胞对肿瘤细胞的识别和攻击能力，从而辅助控制肿瘤生长。

       4、阻断蛋白质相互作用：多肽可以设计成特定的结构，以阻断肿瘤细胞内部或肿瘤微环境中关键蛋白质的相互作用，这些相互作用对于肿瘤的生存和扩散至关重要。

       5、抑制肿瘤新生血管生成：多肽通过抑制血管内皮生长因子（VEGF）等促进血管生成的因子，切断肿瘤的血液供应，抑制肿瘤生长和转移。

       6 、靶向递送：多肽可以通过与其表面受体特异性结合，实现对肿瘤细胞的靶向递送，提高药物的疗效并减少对正常细胞的毒性。

多肽H2N-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2的合成步骤：

1、合成MBHA树脂：取若干克的MBHA树脂（如初始取代度为0.5mmol/g）和1倍树脂摩尔量的Fmoc-Linker-OH加入到反应器中，加入DMF，搅拌使氨基酸完全溶解。再加入树脂2倍量的DIEPA，搅拌混合均匀。再加入树脂0.95倍量的HBTU，搅拌混合均匀。反应3-4小时后，用DMF洗涤3次。用2倍树脂体积的10%乙酸酐/DMF 进行封端30分钟。然后再用DMF洗涤3次，甲醇洗涤2次，DCM洗涤2次，再用甲醇洗涤2次。真空干燥12小时以上，得到干燥的树脂{Fmoc-Linker-MHBA Resin}，测定取代度。这里测得取代度为 0.3mmol/g。结构如下图：

2、脱Fmoc：取1.01g的上述树脂，用DCM或DMF溶胀20分钟。用DMF洗涤2遍。加3倍树脂体积的20%Pip/DMF溶液，鼓氮气30分钟，然后2倍树脂体积的DMF 洗涤5次。得到 H2N-Linker-MBHA Resin 。（此步骤脱除Fmoc基团，茚三酮检测为蓝色，Pip为哌啶）。结构图如下：

3、缩合：取0.91mmol Fmoc-Tyr(tBu)-OH 氨基酸，加入到上述树脂里，加适当DMF溶解氨基酸，再依次加入1.82mmol DIPEA，0.86mmol HBTU。反应30分钟后，取小样洗涤，茚三酮检测为无色。用2倍树脂体积的DMF 洗涤3次树脂。（洗涤树脂，去掉残留溶剂，为下一步反应做准备）。得到Fmoc-Tyr(tBu)-Linker-MBHA Resin。氨基酸：DIPEA：HBTU：树脂=3：6：2.85：1（摩尔比）。结构图如下：

4、依次循环步骤二、步骤三，依次得到

H2N-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Val-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Val-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Leu-Val-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Leu-Val-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Phe-Leu-Val-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Phe-Leu-Val-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Asn(Trt)-Phe-Leu-Val-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Asn(Trt)-Phe-Leu-Val-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Ala-Asn(Trt)-Phe-Leu-Val-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Ala-Asn(Trt)-Phe-Leu-Val-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Leu-Ala-Asn(Trt)-Phe-Leu-Val-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Leu-Ala-Asn(Trt)-Phe-Leu-Val-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Arg(Pbf)-Leu-Ala-Asn(Trt)-Phe-Leu-Val-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Arg(Pbf)-Leu-Ala-Asn(Trt)-Phe-Leu-Val-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Gln(Trt)-Arg(Pbf)-Leu-Ala-Asn(Trt)-Phe-Leu-Val-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Gln(Trt)-Arg(Pbf)-Leu-Ala-Asn(Trt)-Phe-Leu-Val-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Thr(tBu)-Gln(Trt)-Arg(Pbf)-Leu-Ala-Asn(Trt)-Phe-Leu-Val-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

H2N-Thr(tBu)-Gln(Trt)-Arg(Pbf)-Leu-Ala-Asn(Trt)-Phe-Leu-Val-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

Fmoc-Ala-Thr(tBu)-Gln(Trt)-Arg(Pbf)-Leu-Ala-Asn(Trt)-Phe-Leu-Val-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin

以上中间结构，均可在专肽生物多肽计算器-多肽结构计算器中，一键画出。

最后再经过步骤二得到 H2N-Ala-Thr(tBu)-Gln(Trt)-Arg(Pbf)-Leu-Ala-Asn(Trt)-Phe-Leu-Val-Arg(Pbf)-Ser(tBu)-Ser(tBu)-Asn(Trt)-Asn(Trt)-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr(tBu)-Asn(Trt)-Val-Gly-Ser(tBu)-Asn(Trt)-Thr(tBu)-Tyr(tBu)-Linker-MBHA Resin，结构如下：

5、切割：6倍树脂体积的切割液（或每1g树脂加8ml左右的切割液），摇床摇晃 2小时，过滤掉树脂，用冰无水乙醚沉淀滤液，并用冰无水乙醚洗涤沉淀物3次，最后将沉淀物放真空干燥釜中，常温干燥24小试，得到粗品H2N-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2。结构图见产品结构图。

切割液选择：1）TFA：H2O=95%：5%

2）TFA：H2O：TIS=95%：2.5%：2.5%

3）三氟乙酸：茴香硫醚：1，2-乙二硫醇：苯酚：水=87.5%：5%：2.5%：2.5%：2.5%

（前两种适合没有容易氧化的氨基酸，例如Trp、Cys、Met。第三种适合几乎所有的序列。）

6、纯化冻干：使用液相色谱纯化，收集目标峰液体，进行冻干，获得蓬松的粉末状固体多肽。不过这时要取小样复测下纯度 是否目标纯度。

7、最后总结：

杭州专肽生物技术有限公司（ALLPEPTIDE https://www.allpeptide.com）主营定制多肽合成业务，提供各类长肽，短肽，环肽，提供各类修饰肽，如：荧光标记修饰（CY3、CY5、CY5.5、CY7、FAM、FITC、Rhodamine B、TAMRA等），功能基团修饰肽（叠氮、炔基、DBCO、DOTA、NOTA等），同位素标记肽（N15、C13），订书肽（Stapled Peptide）,脂肪酸修饰肽（Pal、Myr、Ste），磷酸化修饰肽（P-Ser、P-Thr、P-Tyr），环肽（酰胺键环肽、一对或者多对二硫键环），生物素标记肽，PEG修饰肽，甲基化修饰肽等。

以上所有内容，为专肽生物原创内容，请勿发布到其他网站上。